Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

URBAN INFLUENCES ON THE DISTRIBUTION OF AIR TEMPERATURE AND RELATIVE HUMIDITY IN BUCHAREST MUNICIPALITY. THE HEAT ISLAND

Autor: Marin VLĂDUCU, Dumitru TÂŞTEA, Carmen-Sofia DRAGOTĂ, Gheorghe KUCSICSA, Ines GRIGORESCU

Publikováno v: Analele Universității din Craiova. Seria Geografie, Vol X, Pp 13-20 (2007)

Bucharest Municipality and its surroundings are situated in the South-Eastern part of the Romanian Plain in a temperate-continental climate, characterized by a continentalization tendency as a result of the climatic influences of transition in the We

Externí odkaz: https://doaj.org/article/0371d6eccc47439cb8a470cafde61d75

Quantitative Measurement of Rate of Targeted Protein Degradation.

Autor: Lynch TL 4th; Quantitative, Translational & ADME Sciences, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Marin VL; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., McClure RA; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Phipps C; Quantitative, Translational & ADME Sciences, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Ronau JA; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Rouhimoghadam M; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Adams AM; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Kandi S; Quantitative, Translational & ADME Sciences, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Wolke ML; Quantitative, Translational & ADME Sciences, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Shergalis AG; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Potts GK; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Nacham O; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Richardson P; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Kakavas SJ; Target Enabling Technologies, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Chhor G; Target Enabling Technologies, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Jenkins GJ; Quantitative, Translational & ADME Sciences, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Woller KR; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Warder SE; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Vasudevan A; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States., Reitsma JM; Technology & Therapeutic Platforms, AbbVie Incorporated, 1 North Waukegan Rd., North Chicago, Illinois 60064, United States.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2024 Jul 19; Vol. 19 (7), pp. 1604-1615. Date of Electronic Publication: 2024 Jul 09.

Controlling cellular distribution of drugs with permeability modifying moieties.

Autor: Richardson PL; Drug Discovery Science and Technologies , 1 North Waukegan Rd , North Chicago , IL 60064 , USA . Email: paul.l.richardson@abbvie.com., Marin VL; Drug Discovery Science and Technologies , 1 North Waukegan Rd , North Chicago , IL 60064 , USA . Email: paul.l.richardson@abbvie.com., Koeniger SL; Drug Discovery Science and Technologies , 1 North Waukegan Rd , North Chicago , IL 60064 , USA . Email: paul.l.richardson@abbvie.com., Baranczak A; Drug Discovery Science and Technologies , 1 North Waukegan Rd , North Chicago , IL 60064 , USA . Email: paul.l.richardson@abbvie.com., Wilsbacher JL; Discovery Oncology , AbbVie Inc. , USA., Kovar PJ; Discovery Oncology , AbbVie Inc. , USA., Bacon-Trusk PE; Discovery Oncology , AbbVie Inc. , USA., Cheng M; Discovery Oncology , AbbVie Inc. , USA., Hopkins TA; Discovery Oncology , AbbVie Inc. , USA., Haman ST; Discovery Oncology , AbbVie Inc. , USA., Vasudevan A; Drug Discovery Science and Technologies , 1 North Waukegan Rd , North Chicago , IL 60064 , USA . Email: paul.l.richardson@abbvie.com.

Publikováno v: MedChemComm [Medchemcomm] 2019 Apr 18; Vol. 10 (6), pp. 974-984. Date of Electronic Publication: 2019 Apr 18 (Print Publication: 2019).

SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT).

Autor: Curtin ML; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States. Electronic address: mike.curtin@abbvie.com., Heyman HR; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Clark RF; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Sorensen BK; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Doherty GA; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Hansen TM; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Frey RR; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Sarris KA; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Aguirre AL; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Shrestha A; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Tu N; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Woller K; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Pliushchev MA; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Sweis RF; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Cheng M; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Wilsbacher JL; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Kovar PJ; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Guo J; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Cheng D; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Longenecker KL; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Raich D; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Korepanova AV; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Soni NB; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Algire MA; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Richardson PL; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Marin VL; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Badagnani I; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Vasudevan A; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Buchanan FG; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Maag D; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Chiang GG; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Tse C; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States., Michaelides MR; AbbVie Inc, 1 North Waukegan Rd., North Chicago, IL 60064, United States.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Aug 01; Vol. 27 (15), pp. 3317-3325. Date of Electronic Publication: 2017 Jun 14.